Holen Sie sich die Stockscreener-App
3.10
5.49%
-0.18
Handel nachbörslich:
3.13
0.03
+0.97%
Schlusskurs vom Vortag:
$3.28
Offen:
$3.39
24-Stunden-Volumen:
219.33K
Relative Volume:
8.75
Marktkapitalisierung:
$146.95M
Einnahmen:
$27,600
Nettoeinkommen (Verlust:
$-36.04M
KGV:
-1.7492
EPS:
-1.7722
Netto-Cashflow:
$-1.66M
1W Leistung:
-6.91%
1M Leistung:
-23.80%
6M Leistung:
-26.31%
1J Leistung:
-53.31%
1-Tages-Spanne:
$3.10
$3.39
1-Wochen-Bereich:
$3.10
$3.69
52-Wochen-Spanne:
$2.76
$8.962
Nanobiotix Adr Stock (NBTX) Company Profile
Vergleichen Sie NBTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NBTX
Nanobiotix Adr
|
3.10 | 146.95M | 27,600 | -36.04M | -1.66M | -0.7968 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Nanobiotix Adr Stock (NBTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-28 | Eingeleitet | Guggenheim | Buy |
| 2023-12-08 | Eingeleitet | Leerink Partners | Outperform |
| 2021-01-06 | Eingeleitet | Evercore ISI | Outperform |
Nanobiotix Adr Aktie (NBTX) Neueste Nachrichten
NANOBIOTIX Provides Third Quarter 2024 Update and Progress on Nanotherapeutics Platforms - GlobeNewswire Inc.
NANOBIOTIX Reports New Data for Potential First-in-Class Radioenhancer NBTXR3 in Combination With Anti-PD-1 Showing Local or Distant Tumor Regression in 76.9% of Evaluable Patients Regardless of Prior Anti-PD-1 Exposure - Business Wire
NANOBIOTIX Partners With LianBio to Develop and Commercialize Potential First-in-Class Radioenhancer NBTXR3 Across Tumor Types and Therapeutic Combinations in China and Other Asian Markets - Business Wire
NBTX News Today | Why did Nanobiotix stock go up today? - MarketBeat
Nanobiotix (NBTX) Stock Price, News & Analysis - MarketBeat
Nanobiotix - Massachusetts Biotechnology Council
Finanzdaten der Nanobiotix Adr-Aktie (NBTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):